Download PDFPDF

Dose regimen for vancomycin not needing serum peak levels?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Authors reply to Dr Sunil's letter

    Dear Editor

    We are grateful to Dr Sunil for highlighting the issue of concommitent aminogycoside use with vancomycin. We agree that sick preterms are different and that it would be imprudent to abandon measuring vancomycin serum levels altogether. However, we do not change our recommendation that trough levels are sufficient in most cases. We are not aware of any data showing that concommitent use of aminoglycosi...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Role of serum peak levels of vancomycin in NICUs

    Dear Editor

    The purpose of measuring serum levels of a drug is either to monitor the toxicity of the drug or the therapeutic concentration for a particular condition. Emergence of infections with beta-lactam-resistant Staphylococcus epidermidis, Staphylococcus aureus, and Enterococcus sp. has led to the frequent use of vancomycin in neonates. Vancomycin historically has had a reputation for tox...

    Show More
    Conflict of Interest:
    None declared.